Javascript is disabled in your browser

Startbase requires Javascript in order to display content.
Please check your browser settings and enable Javascript-Support for this website.

Biotech

News Differential Bio secures €2 million pre-seed The Munich-based AI biotech start-up Differential Bio is emerging from stealth mode. The virtual scale-up platform aims to make bio-based production processes more efficient and scalable.

Marc Nemitz 27.03.2025

News Hubble Therapeutics closes USD 7.3 million Series A financing The funds will be used for the further clinical development of the gene therapy HUB-101, which focuses on rare eye diseases such as LCA16.

Marc Nemitz 25.03.2025

News Mycoprotein production - Kynda secures 3 million euro seed With the support of Enjoy Ventures, PHW Group and Clima Now, the start-up is scaling up its sustainable fermentation solution for food and animal feed production.

Marc Nemitz 19.02.2025

News InfectoPharm invests in AudioCure InfectoPharm joins AudioCure Pharma as a new investor. Together with MED-EL and High-Tech Gründerfonds, the development of AC102 is to be further advanced

Marc Nemitz 13.02.2025

News Bürkert Fluid Control Systems invests in Green Elephant Biotech The strategic partnership with the start-up is intended to enable resource-saving bioreactors for the pharmaceutical industry.

Marc Nemitz 13.02.2025

News Phaeosynt secures 1.7 million euros seed for market entry With a successful financing round, Phaeosynt is ready for the next phase of growth. The biotech start-up focuses on vegan antibody technology for sustainable diagnostics.

Marc Nemitz 12.02.2025

Reports Germany leads the way in oncology start-ups Germany is one of the European leaders in cancer-related patents and start-ups. However, according to a new study by the EPO, scaling up remains a challenge.

Marc Nemitz 03.02.2025

News SRTD biotech receives seed financing The seed funding makes it possible to further develop a platform for targeted RNA therapies. The goal: better cancer therapies without side effects.

Marc Nemitz 14.11.2024

News BioNTech acquires Biotheus for 800 million euros The acquisition of Biotheus gives BioNTech worldwide rights to BNT327/PM8002 and further advances research into innovative combination cancer therapies.

Marc Nemitz 13.11.2024

News SynOx Therapeutics increases capital to USD 92 million in Series B financing Gilde Healthcare leads Series B extension and supports Phase 3 TANGENT study for emactuzumab, a promising CSF-1R-targeted therapy for tenosynovial giant cell tumor

Marc Nemitz 30.10.2024

1
2
3